Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain flag Spain · Delayed Price · Currency is EUR
69.60
+0.40 (0.58%)
Nov 16, 2026, 5:35 PM CET

BME:ROVI Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
828.59743.48763.75829.51817.7648.68
Revenue Growth
14.41%-2.65%-7.93%1.44%26.06%54.46%
Gross Profit
548.85471.59467.71483.34512.43379.84
Operating Income
167.61173.14178.71219.47253.74180.15
Net Income
205.57140.44136.88170.34199.67153.08
Earnings Per Share
4.022.752.673.203.732.76
EPS Growth
-2.73%-16.53%-14.25%35.31%150.36%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Manufacturing
494.13600.35644.41619.23471.79
Other
0.1----
Inter-Segment Transactions
-224.63-264.13-235.13-215.69-207.09
Marketing
473.89427.53420.23414.15383.98
Total
743.48763.75829.51817.7648.68

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
70.9298.628.0225.44125.0399.14
Total Debt
100.95121.82114.4165.4372.1773.16
Net Cash (Debt)
-30.03-23.22-86.39-39.9952.8725.97
Net Cash Growth
----103.55%-
Net Cash Per Share
-0.59-0.45-1.69-0.750.990.47

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
196.72187.08138.28113.25237.6149.44
Capital Expenditures
-75.94-65.21-59.12-53.79-50.72-40.22
Free Cash Flow
120.78121.8779.1659.45186.88109.22
Free Cash Flow Growth
8.79%53.95%33.15%-68.19%71.10%1348.77%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
66.24%63.43%61.24%58.27%62.67%58.55%
Operating Margin
20.23%23.29%23.40%26.46%31.03%27.77%
Pretax Margin
30.75%24.65%23.27%26.57%31.55%28.15%
Profit Margin
24.81%18.89%17.92%20.53%24.42%23.60%
FCF Margin
14.58%16.39%10.37%7.17%22.86%16.84%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.9590.9590.9351.1041.2940.956
Dividend Per Share Growth
2.60%2.60%-15.28%-14.69%35.39%150.68%
Dividend Yield
1.38%1.51%1.49%1.78%3.59%1.27%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
17.3223.1323.5218.869.6427.03
Forward PE
21.8421.5819.0219.7612.7625.70
P/FCF Ratio
29.4926.6540.6854.0410.3037.89
PS Ratio
4.304.374.223.872.356.38